"Beond the Biopsy" How NASH Therapy Will Improve When Non-Invasive Tests Become The Standard - Ep 26
Send us a text The Surfers discuss the Global Liver Institute's campaign to educate and motivate key stakeholder groups on the value of non-invasive liver testing. Donna Cryer, President and CEO of the Global Liver Institute, discusses GLI's "Beyond the Biopsy" campaign while Stephen Harrison, Louise Campbell, and Roger Green join in with education, messages, and ideas. The "Beyond the Biopsy" campaign focuses on the importance of gaining acceptance for non-invasive liver testing. Stephen d...
17 Sep 202051min
What Exactly Are We Trying To Achieve In Early-Stage NASH Therapy? Ep 25
Send us a text The Surfers and guest Joern Schattenberg consider the implications of a Digital ILC presentation stating that the liver, not cardiovascular disease, is the leading cause of death for NAFLD patients. The Surfers considered the implication of a Digital ILC presentation by James Paik et al. titled "Causes of death in patients with non-alcoholic fatty liver disease (NAFLD): data from national vital statistics system (NVSS)." The presentation demonstrated that liver disease, not ca...
10 Sep 202057min
EASL Digital ILC 2020 Wrap-Up: A Complicated Picture Emerges - Ep 24
Send us a text Professors Joern Shcattenberg and Vlad Ratziu join the Surfers to discuss the lessons and findings we can take away from Digital ILC 2020. What happens when seven people with diverse and divergent perspectives consider the implications of last week's Digital ILC meeting? Professors Vlad Ratziu and Joern Schattenberg join the Surfers to reflect on many insights, some leading to clashing outlooks. From Peter Traber's opening comments about the increasing convergence and energy a...
2 Sep 20201h 8min
Digital ILC Day Three Highlights: Late breakers, COVID and more - Ep 23
Send us a text SurfingNASH's Digital ILC coverage ends with three late-breaking drug presentations, a discussion of EASL's COVID efforts, and insights on patient management. Professor Joern Schattenberg joins the Surfers to discuss the last day of Digital ILC. Donna Cryer and Roger Green praise the work EASL has done pulling together data and analysis on how #liverdisease affects #COVID19 treatment decisions and outcomes, while Louise Campbell discusses research-in-process and Stephen, Peter...
29 Aug 20201h 23min
Digital ILC Day Two Highlights: A Fork in the Road - Ep 22
Send us a text Drugs in development and diagnostics show promise but healthcare has far to go in identifying and treating patients in need. Professor Vlad Ratziu joins the Surfers to discuss Day Two's presentation. The day produced exciting presentations about drugs in development and suggestive findings of the role non-invasive tests and markers can play in predicting patient success. At the same time, other presentations focused on the challenges and opportunities involved in identifying a...
28 Aug 20202h 7min
Digital ILC Day One Highlights: Much to Think About - Ep 21
Send us a text One day into the first-ever digital major conference, the Surfers review six presentations and one interactive session. A lot was learned, much of which did not fit into neat categories. The Surfers and guest Naim Alkhouri reviewed six presentations and one interactive session formally (points from other presentations crept in once or twice). Like the day itself, the group came to a few clear conclusions or consensus, except that AI/machine learning has a larger role to play g...
28 Aug 20201h 22min
How will Digital ILC be different from past conferences? - Ep 20
Send us a text The group discusses the plusses and minuses of digital conferences compared to traditional in-person events. Digital ILC starts Thursday, August 27. Donna Cryer, who oversaw the first Digital International NASH Day this year, and Stephen Harrison, who co-chairs NASH-TAG, discuss the factors that organizers consider when deciding whether to go digital and planning how to make it work. The discussion reveals some powerful benefits for a digital meeting in terms of how many peopl...
27 Aug 202057min
What NASH patients want from outside the healthcare system - Ep 19
Send us a text The second part of the "What NASH patients want" series focuses on the future of healthcare apps and the role government agencies such as FDA, NIH, CMS, and EMEA can play in providing hope or increasing concern and anxiety based on their decisions and the consistency of their messages. In discussing apps, Fatty Liver Foundation President Wayne Eskridge, a trained electrical engineer, envisions a future when patients can receive continuous readings on key metrics using an implan...
20 Aug 202054min
